Toshiba America Medical Systems of Tustin, CA, is sponsoring a coronary heart disease study with its wall motion tracking ultrasound technology, the company said.
Speckle Tracking by Echo is a substudy of faCTor64, a study with Intermountain Healthcare of Salt Lake City to assess asymptomatic diabetics using cardiac CT angiography (CTA) with Toshiba's Aquilion 64 multidetector-row CT system.
The substudy evaluates an asymptomatic diabetic population for heart disease by detecting if patients have a reduction in myocardial strain. Strain is the percentage change in muscle as the heart contracts. Any reduction in strain indicates a strong possibility of heart disease, so the patient is sent to CT for further evaluation, according to Toshiba.
Intermountain Healthcare hopes to enroll more than 300 patients from its diabetes registry in the substudy, Toshiba said.
Related Reading
Toshiba highlights CT software at ECR, March 6, 2010
Toshiba launches Aquilion cardiac software, March 1, 2010
Toshiba promotes Ryan to VP spot, February 23, 2010
FDA clears Toshiba's Viamo ultrasound, February 4, 2010
Toshiba nets midsized Infinix VF-i install, January 27, 2010
Copyright © 2010 AuntMinnie.com
